("Company" or the "Group")
Share Purchase by Non-Executive Director
Gateley (AIM: GTLY), the professional services group, announces that it has been notified that the Company's Non-Executive Director,
Following the transaction,
|
|
|
|
||||||||
|
|
Tel: +44 (0) 121 234 0196 |
|
||||||||
|
|
Tel +44 (0) 20 7653 1665 |
|
||||||||
|
|
Tel +44 (0) 121 234 0074 Mob: +44 (0) 7703 684 946 |
|
||||||||
|
|
|
|
||||||||
|
Panmure Liberum - Nominated Adviser and Broker |
|
|
||||||||
|
Nicholas Know / |
Tel: +44 (0) 20 3100 2167
|
|
||||||||
|
Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014 |
||||||||||
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||||
|
a. |
|
|
||||||||
|
2 |
Reason for notification |
|
||||||||
|
a. |
Position/Status |
Non-Executive Director |
||||||||
|
b. |
Initial notification/ Amendment |
Initial Notification |
||||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||
|
a. |
|
|
||||||||
|
b. |
LEI |
213800WZGNN7U6LEUM62 |
||||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||
|
a. |
Description of the financial instrument, type of instrument |
Ordinary Shares of
ISIN: GB00BXB07J71 |
||||||||
|
b. |
Nature of the transaction |
Purchase of Ordinary Shares |
||||||||
|
c. |
Price(s) and volume(s) |
|
|
|
|
|
||||
|
|
Price(s) |
Volume(s) |
|
|||||||
|
|
40,000 |
|
||||||||
|
d. |
Aggregated information - Aggregated Volume - Price |
40,000 |
||||||||
|
e. |
Date of the transaction |
|
||||||||
|
f. |
Place of the transaction |
|
||||||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the